Research & Development in
Pfäffikon SZ

Oerlikon Surface Solutions AG, Pfäffikon

Since 1995 · 21–50 empl.

Oerlikon Surface Solutions AG, Pfäffikon provides surface solutions for industrial applications. Its portfolio includes materials, coating equipment, coating services and technical support, with a focus on thermal spray technologies.

IFCC Foundation for Emerging Nations

Since 2016 · 11–20 empl.

The company's core activity is the promotion and support of educational and research projects in the field of laboratory medicine, particularly in the areas of clinical chemistry, hematology, and microbiology. The company, the IFCC Foundation (FEN), is a foundation that focuses on supporting projects that improve the quality and value of laboratory medicine in healthcare. The foundation specifically promotes the development of educational programs, workshops, and research projects that focus on improving laboratory medicine.

LamKap Bio beta AG

Since 2017 · 1–10 empl.

LamKap Bio beta AG researches, develops and manufactures fully human bispecific antibodies for the treatment of solid tumors. Its pipeline includes molecules designed to selectively block CD47 on tumor cells and bispecifics that retarget immune effector cells such as macrophages, T cells and natural killer cells.

LamKap Bio alpha AG

Since 2018 · 1–10 empl.

LamKap Bio alpha AG is a LamKap Bio group program that researches, develops and manufactures fully human bispecific antibodies for the treatment of solid tumours. The approach redirects patients' immune effector cells (macrophages, T cells and natural killer cells) to target cancer cells; the pipeline includes candidates with target combinations such as CEA×CD3, CEA×CD28 and CEA×CD47.

LamKap Bio gamma AG

Since 2018 · 1–10 empl.

LamKap Bio gamma AG is a biotechnology company that researches, develops, manufactures and tests fully human bispecific antibodies for cancer immunotherapy, particularly for solid tumors. Its molecules are designed to redirect immune effector cells (macrophages, T cells, natural killer cells) to attack tumor cells and include programs targeting CD47, CD3, CD28 and tumor-associated antigens such as CEA and GPC3.

Mindfire AG

Since 2019 · 11–20 empl.

The core activity of Mindfire AG is the research and development of artificial intelligence (AI) with the goal of expanding the boundaries of human potential by combining AI and collective intelligence. The company operates the AI-Lab Lab42, which focuses on the development of human-level AI, i.e. AI that prioritizes the interests of humanity.

discoveric bio beta ag

Since 2019 · 21–50 empl.

discoveric bio beta ag develops fully human bi- and multispecific antibodies for the treatment of Alzheimer’s disease and antimicrobial-resistant infections. The company advances candidates from discovery through preclinical and clinical development toward commercialization and collaborates with external experts and CROs.

discoveric marina ag

Since 2020 · 21–50 empl.

discoveric marina ag develops fully human bi- and multi-specific antibodies and advances programs targeting Alzheimer’s disease, neuroinflammation and antimicrobial‑resistant infections.

discoveric marketplace ag

Since 2021 · 21–50 empl.

discoveric marketplace ag develops fully human bi- and multi-specific IgG antibodies and advances therapeutic programs focused on Alzheimer’s disease, neuroinflammation and antimicrobial‑resistant infections.

Medable GmbH

Since 2021 · 1–10 empl.

Medable GmbH provides a unified decentralized clinical trial (DCT) platform offering eCOA/ePRO, eConsent, remote monitoring, and integration with connected sensors and wearables. The platform includes agentic AI tools such as Agent Studio to automate study tasks and supports integrations, participant apps and study reporting for sponsors, CROs and sites.

LRE Medical Switzerland AG

Since 2024 · 1–10 empl.

LRE Medical Switzerland AG is a contract development and manufacturing organization (CDMO) specializing in the development and industrialization of complex diagnostic, medical and life‑science devices. Services include product development and engineering, production engineering and manufacturing, quality and regulatory support, and lifecycle management with after‑sales services for point‑of‑care and benchtop laboratory instruments.

Livinguard PackTech AG

Since 2026 · 11–20 empl.

Livinguard PackTech AG is a Swiss material science company that develops technologies to improve the functionality, performance and durability of materials. The company offers solutions for textiles, sustainable dyeing, nonwovens, air filtration and hygiene products.